// App-Quantinova.ai

3047 : Concordancy of immunocytochemistry profiling of circulating tumor cells with immunohistochemistry for analysis of therapeutically relevant biomarkers.

Researchers

Presenter

  • Dadasaheb B Akolkar

Principal Investigators

  • Darshana Patil

  • Sudha S Murthy

  • Kiran Bendale

  • Revati Patil

  • Vineet Datta

  • Pradip Fulmali

  • Pooja Fulmali

  • Archana Adhav

  • Shoeb Patel

  • Rohit Chougule

  • Vishal Ranjan

  • Shabista Khan

  • Raja Dhasarathan

  • Sachin Apurwa

  • Stefan Schuster

  • Ajay Srinivasan

  • Rajan Datar

Medical Centers

  • Datar Cancer Genetics Limited, Nasik, India

  • Datar Cancer Genetics Europe GmbH, Bayreuth, Germany

Locations

  • India

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Cluster of Differentiation 206

  • Programmed death-ligand 1

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A